Protocol S2212, Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study (NCT TBD)

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Locations

Memorial Hospital Central
Memorial Hospital North

Principal Investigator
Photograph of Uchenna Njiaju

Uchenna Njiaju

Study ID

Protocol Number: 23-2438

More information available at ClinicalTrials.gov: NCT05929768

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers